CompletedNot Applicable

Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination

United States9,242 participantsStarted 2018-04-01

Plain-language summary

Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been disappointingly low and lags behind other adolescent vaccines. This study seeks to test interventions targeting health care system, provider, and patient factors to improve the population uptake of the HPV vaccine.

Who can participate

Age range11 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Empaneled in one of the six participating primary care practices * 11 to 12 years of age at the first day of each of the 12-month-long steps * Due during that 12-month-long step for at least one dose of the HPV vaccine Exclusion Criteria: * Not empaneled in one of the six participating practices * Empaneled in one of the six participating practices but less than 11 years of age or more than 12 years of age on the first day of each 12 month long step * Not due during that 12-month-long step for a dose of HPV vaccine.

What they're measuring

Human Papillomavirus or HPV-vaccine-dose Receipt

Timeframe: The dose had to have been received during the 12-month-long study step.

Trial details

NCT IDNCT03501992

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-31

Results submitted2024-02-26

View on ClinicalTrials.gov More Papillomavirus Vaccines trials